LAMIVUDINE\ZIDOVUDINE: 2,610 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
2,610
Total FAERS Reports
245 (9.4%)
Deaths Reported
418
Hospitalizations
2,610
As Primary/Secondary Suspect
67
Life-Threatening
36
Disabilities
First Report: 1996 · Latest Report: 20241201
What Are the Most Common LAMIVUDINE\ZIDOVUDINE Side Effects?
#1 Most Reported
Foetal exposure during pregnancy
622 reports (23.8%)
#2 Most Reported
Maternal exposure during pregnancy
284 reports (10.9%)
#3 Most Reported
Exposure during pregnancy
280 reports (10.7%)
All LAMIVUDINE\ZIDOVUDINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Foetal exposure during pregnancy | 622 | 23.8% | 101 | 71 |
| Maternal exposure during pregnancy | 284 | 10.9% | 6 | 30 |
| Exposure during pregnancy | 280 | 10.7% | 9 | 27 |
| Virologic failure | 231 | 8.9% | 6 | 2 |
| Drug resistance | 147 | 5.6% | 0 | 8 |
| Viral mutation identified | 145 | 5.6% | 0 | 4 |
| Premature baby | 144 | 5.5% | 13 | 34 |
| Pathogen resistance | 137 | 5.3% | 0 | 12 |
| Anaemia | 130 | 5.0% | 10 | 50 |
| Abortion spontaneous | 119 | 4.6% | 3 | 1 |
| Lipodystrophy acquired | 98 | 3.8% | 0 | 23 |
| Treatment noncompliance | 96 | 3.7% | 1 | 15 |
| Premature delivery | 85 | 3.3% | 2 | 11 |
| Low birth weight baby | 78 | 3.0% | 4 | 9 |
| Exposure during breast feeding | 74 | 2.8% | 39 | 1 |
| Nausea | 71 | 2.7% | 1 | 30 |
| Diarrhoea | 70 | 2.7% | 3 | 43 |
| Drug ineffective | 67 | 2.6% | 0 | 15 |
| Live birth | 65 | 2.5% | 0 | 21 |
| Dandy-walker syndrome | 56 | 2.2% | 20 | 2 |
Who Reports LAMIVUDINE\ZIDOVUDINE Side Effects? Age & Gender Data
Gender: 57.3% female, 42.7% male. Average age: 34.7 years. Most reports from: US. View detailed demographics →
Is LAMIVUDINE\ZIDOVUDINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 21 | 0 | 7 |
| 2001 | 39 | 1 | 9 |
| 2002 | 35 | 2 | 20 |
| 2003 | 15 | 3 | 9 |
| 2004 | 24 | 0 | 3 |
| 2005 | 21 | 6 | 10 |
| 2006 | 35 | 6 | 10 |
| 2007 | 27 | 0 | 12 |
| 2008 | 20 | 0 | 3 |
| 2009 | 48 | 1 | 17 |
| 2010 | 32 | 1 | 8 |
| 2011 | 51 | 17 | 11 |
| 2012 | 58 | 9 | 15 |
| 2013 | 50 | 2 | 14 |
| 2014 | 155 | 16 | 23 |
| 2015 | 110 | 9 | 16 |
| 2016 | 54 | 2 | 15 |
| 2017 | 77 | 1 | 40 |
| 2018 | 32 | 1 | 11 |
| 2019 | 31 | 6 | 5 |
| 2020 | 20 | 1 | 4 |
| 2021 | 34 | 1 | 2 |
| 2022 | 38 | 5 | 7 |
| 2023 | 5 | 1 | 2 |
| 2024 | 5 | 1 | 0 |
What Is LAMIVUDINE\ZIDOVUDINE Used For?
LAMIVUDINE\ZIDOVUDINE vs Alternatives: Which Is Safer?
LAMIVUDINE\ZIDOVUDINE vs LAMOTRIGINE
LAMIVUDINE\ZIDOVUDINE vs LANADELUMAB
LAMIVUDINE\ZIDOVUDINE vs LANADELUMAB-FLYO
LAMIVUDINE\ZIDOVUDINE vs LANREOTIDE
LAMIVUDINE\ZIDOVUDINE vs LANSOPRAZOLE
LAMIVUDINE\ZIDOVUDINE vs LANTHANUM
LAMIVUDINE\ZIDOVUDINE vs LANTUS
LAMIVUDINE\ZIDOVUDINE vs LANTUS SOLOSTAR
LAMIVUDINE\ZIDOVUDINE vs LAPATINIB
LAMIVUDINE\ZIDOVUDINE vs LAPATINIB DITOSYLATE
Official FDA Label for LAMIVUDINE\ZIDOVUDINE
Official prescribing information from the FDA-approved drug label.